Literature DB >> 7076299

Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media.

J S Abramson, G S Giebink, P G Quie.   

Abstract

The role of influenza A virus-induced polymorphonuclear leukocyte and eustachian tube dysfunction in the pathogenesis of acute purulent otitis media was studied in chinchillas. Polymorphonuclear leukocyte function, middle ear pressure, and the incidence of pneumococcal otitis media were observed after intranasal inoculation with influenza A virus, Streptococcus pneumoniae, or both. Results showed that depressed negative middle ear pressure and polymorphonuclear leukocyte chemiluminescence and chemotactic activity occurred after influenza inoculation, but not after inoculation with pneumococcus alone. The greatest incidence of pneumococcal otitis media occurred when the pneumococcus was inoculated just before the time of influenza-induced polymorphonuclear leukocyte dysfunction and negative middle ear pressure. Animals that had unilateral tympanostomy tubes placed before inoculation of influenza with pneumococcus showed no difference in the occurrence of pneumococcal otitis media in ventilated and nonventilated ears, suggesting that polymorphonuclear leukocyte dysfunction contributes more to the pathogenesis of pneumococcal otitis media than does negative middle ear pressure in this animal model.

Entities:  

Mesh:

Year:  1982        PMID: 7076299      PMCID: PMC351217          DOI: 10.1128/iai.36.1.289-296.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The bacteriology of pneumococcal otitis media.

Authors:  R Austrian; V M Howie; J H Ploussard
Journal:  Johns Hopkins Med J       Date:  1977-09

2.  The effects of the vacuum on vascular permeability of the middle ear.

Authors:  F Hiraide; H Eriksson
Journal:  Acta Otolaryngol       Date:  1978 Jan-Feb       Impact factor: 1.494

3.  Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas.

Authors:  J S Abramson; G S Giebink; E L Mills; P G Quie
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

4.  The effect of influenza virus on human polymorphonuclear leukocytes.

Authors:  Y Debets-Ossenkopp; W C van Dijk; E L Mills; H A Verbrugh; J Verhoef
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

5.  Eustachian tube function and allergy in otitis media.

Authors:  C D Bluestone
Journal:  Pediatrics       Date:  1978-05       Impact factor: 7.124

6.  Isolation of viruses and mycoplasmas from middle ear effusions: a review.

Authors:  J O Klein; D W Teele
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Mar-Apr       Impact factor: 1.547

7.  Otitis media with effusion. Cytological and microbiological correlates.

Authors:  D J Lim; D M Lewis; J L Schram; H G Birck
Journal:  Arch Otolaryngol       Date:  1979-07

8.  Effect of inflammation of the ventilatory function of the eustachian tube.

Authors:  C D Bluestone; E I Cantekin; Q C Beery
Journal:  Laryngoscope       Date:  1977-04       Impact factor: 3.325

9.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy.

Authors:  G S Giebink; I K Berzins; P G Quie
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1980 May-Jun
View more
  30 in total

1.  Influenza virus induces bacterial and nonbacterial otitis media.

Authors:  Kirsty R Short; Dimitri A Diavatopoulos; Ruth Thornton; John Pedersen; Richard A Strugnell; Andrew K Wise; Patrick C Reading; Odilia L Wijburg
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

Review 2.  Photon emission of phagocytes in relation to stress and disease.

Authors:  E M Lilius; P Marnila
Journal:  Experientia       Date:  1992-12-01

Review 3.  Secondary bacterial infections in influenza virus infection pathogenesis.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 4.  Preventing and treating secondary bacterial infections with antiviral agents.

Authors:  Jonathan A McCullers
Journal:  Antivir Ther       Date:  2011

Review 5.  Modulation of phagocytic cell function.

Authors:  P A Henricks; J Verhoef; F P Nijkamp
Journal:  Vet Res Commun       Date:  1986-05       Impact factor: 2.459

Review 6.  Interactions of viruses with the immune system.

Authors:  C A Mims
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

7.  Depressed chemiluminescence response by influenza virus is enhanced after conjugation of viral subunits to muramyl dipeptide.

Authors:  K N Masihi; W Lange; B Rohde-Schulz; L Chedid; M Jolivet
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media.

Authors:  K Suzuki; L O Bakaletz
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Influenza-induced inflammation drives pneumococcal otitis media.

Authors:  Kirsty R Short; Patrick C Reading; Lorena E Brown; John Pedersen; Brad Gilbertson; Emma R Job; Kathryn M Edenborough; Marrit N Habets; Aldert Zomer; Peter W M Hermans; Dimitri A Diavatopoulos; Odilia L Wijburg
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

10.  Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media.

Authors:  Kirsty R Short; Maren von Köckritz-Blickwede; Jeroen D Langereis; Keng Yih Chew; Emma R Job; Charles W Armitage; Brandon Hatcher; Kohtaro Fujihashi; Patrick C Reading; Peter W Hermans; Odilia L Wijburg; Dimitri A Diavatopoulos
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.